Explain this page
Arphra AIPlain-English read on Bio-Techne Corporation’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$27.77
-46.22% vs spot
Recommendation
Sell
18 of 19 methods
Method spread
1bull17bear
±5% threshold
Analyst PT consensus: $69.33 (+34.24%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.89% | +2.05% | -8.88% | -7.60% | -16.27% | -12.18% | +6.90% | -37.53% | -50.78% | +84.25% | +47116.13% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$5.55M
10 txns
Net flow
−$5.55M
Aftermarket
LiveLast trade
$51.65
2 sh
Bid
$51.63
2 sh
Ask
$51.66
2 sh
Spread
$0.030
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 Dec 2025 | $295.88M | $38.01M | $0.24 |
| Q1 Sep 2025 | $286.56M | $38.19M | $0.24 |
| Q4 Jun 2025 | $316.96M | -$17.68M | $-0.11 |
| Q3 Mar 2025 | $316.18M | $22.59M | $0.14 |
| Q2 Dec 2024 | $297.03M | $34.89M | $0.22 |
| Q1 Sep 2024 | $289.46M | $33.6M | $0.21 |
Sector & industry today
LiveSectors
- Financial Services+2.29%
- Real Estate+1.60%
- Consumer Defensive+1.50%
- Healthcare+0.52%
- Consumer Cyclical+0.16%
- Utilities+0.08%
- Industrials-0.37%
- Energy-1.04%
- Communication Services-1.29%
- Basic Materials-1.95%
- Technology-2.97%
Top industries (issuer's industry highlighted)
- Biotechnology-1.40%
- Silver-6.59%
- Other Precious Metals-5.83%
- Software - Infrastructure-5.76%
- Copper-5.61%
- Information Technology Services-4.71%
- Gold-4.10%
- Electronic Gaming & Multimedia-4.07%
- REIT - Healthcare Facilities+4.07%
- Coal-3.73%
- Oil & Gas Energy-3.67%
- Medical - Healthcare Information Services-3.67%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$69.33
+34.24% upside
Low
$62.00
Median
$69.00
High
$79.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Bio-Techne Corporation (TECH) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- CMB.TECH announces Q1 2026 results on 19/05/2026globenewswire.com·May 07, 2026
- Bio-Techne Releases Third Quarter Fiscal 2026 Resultsprnewswire.com·May 06, 2026
- Bio-Techne Declares Dividendprnewswire.com·May 06, 2026
Peers
- RVMDRevolution Medicines, Inc.$139.48$29.65B
- MRNAModerna, Inc.$45.37$17.99B
- JAZZJazz Pharmaceuticals plc$202.72$12.72B
- MDGLMadrigal Pharmaceuticals, Inc.$513.72$11.78B
- EXELExelixis, Inc.$43.68$11.1B
- BMRNBioMarin Pharmaceutical Inc.$54.06$10.4B
- QGENQiagen N.V.$34.25$7.06B
- CORTCorcept Therapeutics Incorporated$51.42$5.52B
Total assets
$2.56B
Total debt
$444.06M
Cash & equiv
$162.19M
Operating CF
$287.56M
Free cash flow
$256.55M
Buybacks
-$275.73M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Herr Amy E. director | Sell | 1,976 | $116.79K | Feb 17, 2026 |
Nusse Roeland director | Sell | 17,040 | $960.39K | Aug 25, 2025 |
BAUMGARTNER ROBERT V director | Sell | 17,040 | $957.82K | Aug 25, 2025 |
Herr Amy E. director | Sell | 1,280 | $63.7K | Jun 09, 2025 |
Herr Amy E. director | Sell | 1,860 | $122.69K | Feb 14, 2025 |
Kelderman Kim director, officer: Chief Executive Officer | Sell | 11,731 | $905.53K | Jan 27, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $1.22B | $102.26M | $73.4M | $0.46 | +6.02% |
| FY 2024 | $1.16B | $206.69M | $168.11M | $1.05 | +14.50% |
| FY 2023 | $1.14B | $298.94M | $285.26M | $1.76 | +25.10% |
| FY 2022 | $1.11B | $296.59M | $272.05M | $1.66 | +24.61% |
| FY 2021 | $931.03M | $237.3M | $140.41M | $0.87 | +15.08% |